Healio
›
Hepatology
›
News
-
Health Care Legislative and Regulatory Update
-
-
March 27, 2013
-
From international law firm Arnold & Porter LLP comes timely views on current regulatory and legislative topics that weigh on the minds of today’s...More
»
-
In the Journals
-
-
March 27, 2013
-
Data from a phase 2 trial suggest that adding 12 weeks of sofosbuvir to peginterferon alfa-2a and ribavirin may be beneficial in non-cirrhotic,...More
»
-
In the Journals
-
-
March 27, 2013
-
Most liver transplant candidates are vitamin A- and vitamin D-deficient, with bilirubin levels, BMI and Child-Turcotte-Pugh class predictive of vitamin A...More
»
-
-
-
March 26, 2013
-
Physician-owned distributorships are the target of a new special fraud alert issued by the Office of Inspector General.
Citing the “strong potential...More
»
-
In the Journals
-
-
March 26, 2013
-
More than 20% of patients with chronic hepatitis C treated with interferon developed hyperpigmentation as a side effect of therapy in a recent study.
...More
»
-
In the Journals
-
-
March 26, 2013
-
Screening high-risk, newly incarcerated patients could identify more than 7,000 acute hepatitis C virus infections among those who use injection drugs,...More
»
-
In the Journals
Perspective
-
-
March 26, 2013
-
Vaccination with hepatitis B immunoglobulin for neonates of hepatitis B surface antigen carrier mothers is a cost-effective addition to universal...More
»
-
In the Journals
-
-
March 25, 2013
-
Medication nonadherence during the first 24 weeks of treatment for chronic hepatitis C was often deliberate and attributed to feeling well, as opposed to...More
»
-
In the Journals
-
-
March 22, 2013
-
Patients with chronic HBV treated with long-term entecavir developed hepatocellular carcinoma significantly less frequently than untreated controls in a...More
»
-
In the Journals
-
-
March 21, 2013
-
While psychological illness and alcohol consumption can reduce treatment response in patients with chronic hepatitis C, the effect of other behavioral and...More
»